Integra LifeSciences Holdings Corporation (IART) financial statements (2022 and earlier)

Company profile

Business Address 1100 CAMPUS ROAD
PRINCETON, NJ 08540
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments51347019913917510248
Cash and cash equivalents51347019913917510248
Restricted cash and investments      4
Receivables232226275266252148132
Inventory, net of allowances, customer advances and progress billings317310316280296217211
Inventory317310316280296217211
Disposal group, including discontinued operation 162     
Other undisclosed current assets91696890992843
Total current assets:1,1541,237858775822495438
Noncurrent Assets
Operating lease, right-of-use asset858495
Property, plant and equipment312288337300269222205
Intangible assets, net (including goodwill)2,1591,9221,9862,0062,0981,0721,116
Goodwill1,013932954926938511512
Intangible assets, net (excluding goodwill)1,1469891,0321,0791,160561604
Deferred income tax assets577413
Other noncurrent assets1611152016128
Deferred tax assets, net   (148)
Other undisclosed noncurrent assets   767155
Total noncurrent assets:2,6292,3782,4452,3332,3891,3131,336
TOTAL ASSETS:3,7823,6153,3033,1083,2111,8081,775
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities275225269236255117119
Accounts payable625511376942935
Accrued liabilities120947785883539
Employee-related liabilities93767976735345
Deferred revenue555
Debt4534572360 14
Restructuring reserve10      
Disposal group, including discontinued operation 12     
Business combination, contingent consideration, liability    23  
Deferred revenue and credits1176
Contract with customer, liability4
Other undisclosed current liabilities5125     
Total current liabilities:340401331263349124139
Noncurrent Liabilities
Long-term debt and lease obligation1,4791,4961,2961,2111,781665701
Long-term debt, excluding current maturities1,3891,4081,1991,2111,781665701
Operating lease, liability908898
Liabilities, other than long-term debt17320316289543129
Deferred revenue7 7
Contract with customer, liability9
Deferred income tax liabilities461637
Other liabilities12018711880543129
Other undisclosed noncurrent liabilities106 9717065149155
Total noncurrent liabilities:1,7581,6991,5551,4701,900845884
Total liabilities:2,0982,1001,8871,7322,2499681,023
Stockholders' equity
Stockholders' equity attributable to parent1,6851,5151,4171,376962840751
Common stock1111110
Treasury stock, value(234)(235)(120)(121)(122)(123)(367)
Additional paid in capital1,2651,2911,2141,1938227991,020
Accumulated other comprehensive loss(45)(74)(76)(45)(24)(57)(48)
Retained earnings699532399348285220146
Total stockholders' equity:1,6851,5151,4171,376962840751
TOTAL LIABILITIES AND EQUITY:3,7823,6153,3033,1083,2111,8081,775

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1,5421,3721,5181,4721,188992883
Revenue, net1,188992883
Cost of revenue
(Cost of Goods and Services Sold)
(598)(521)(565)(571)(449)(363)(340)
Other undisclosed gross profit    141414
Gross profit:945851953901753643556
Operating expenses(747)(700)(859)(790)(708)(528)(717)
Other undisclosed operating income      241
Operating income:197151941114511580
Nonoperating income26142011215
Investment income, nonoperating79113000
Other nonoperating income194108115
Interest and debt expense(50)(72)(54)(65)(35)(26)(24)
Income from continuing operations before equity method investments, income taxes:173946057119061
Other undisclosed income from continuing operations before income taxes42      
Income from continuing operations before income taxes:215946057119061
Income tax expense (benefit)(46)40(10)353(16)(54)
Net income:169134506165757
Other undisclosed net loss attributable to parent      (10)
Net income (loss) available to common stockholders, diluted:16913450616575(4)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:169134506165757
Other comprehensive income (loss)(5)21(2)(22)40(11)(24)
Comprehensive income (loss):164155483910463(18)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent34(19)(29) (6)2(10)
Comprehensive income (loss), net of tax, attributable to parent:19813619399865(28)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: